209 related articles for article (PubMed ID: 6750843)
1. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
[TBL] [Abstract][Full Text] [Related]
2. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
Davis TM; Bown E; Turner RC
Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
[TBL] [Abstract][Full Text] [Related]
3. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
4. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
[TBL] [Abstract][Full Text] [Related]
5. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and retinal microangiopathy in diabetes and hypertension.
Khosla PK; Mahabaleswara M; Tiwari HK; Saraya AK
Acta Haematol; 1979; 61(3):161-7. PubMed ID: 108893
[TBL] [Abstract][Full Text] [Related]
7. Abnormal platelet aggregation in chronic symptomatic diabetic peripheral neuropathy.
Jennings PE; Dallinger KJ; Nightingale S; Barnett AH
Diabet Med; 1986 May; 3(3):237-40. PubMed ID: 2951176
[TBL] [Abstract][Full Text] [Related]
8. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
Gisinger C; Schernthaner G
Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
[TBL] [Abstract][Full Text] [Related]
9. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
[TBL] [Abstract][Full Text] [Related]
10. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
Rao GH; Reddy KR; White JG
Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the sensitivity of platelets to ADP and PGI2 in normal and diabetic pregnancies.
Gerö G; Rákóczi I; Tihanyi K; Blaskó G; Oláh J; Sas G
Thromb Res; 1985 Sep; 39(6):781-2. PubMed ID: 3909505
[No Abstract] [Full Text] [Related]
12. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation in type I diabetics with and without proliferative retinopathy.
Agardh CD; Agardh E; Bauer B
Acta Ophthalmol (Copenh); 1987 Jun; 65(3):358-62. PubMed ID: 3618162
[TBL] [Abstract][Full Text] [Related]
14. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
16. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
Akai T; Naka K; Okuda K; Takemura T; Fujii S
Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
Ehrman ML; Jaffe EA
Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical platelet behaviour in diabetic ketoacidosis.
Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
[TBL] [Abstract][Full Text] [Related]
19. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
